Lux Biosciences, based in Jersey City, NJ and focused upon the development of ophthalmic disease, has relied upon an in-licensing strategy from corporate partners and academia for molecules and technologies that have demonstrated proof-of-concept in related non-ophthalmic diseases but where common mechanisms of action and biological pathway overlap may be levered. PRODUCTS IN DEVELOPMENT LX211, [...]